Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus-Reference-Cited by-同舟云学术

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus

Published:2019-12 Issue:6 Volume:2 Page:169-173
ISSN:2574-4593
Container-title:Journal of Cutaneous Immunology and Allergy
language:en
Short-container-title:J Cutan Immunol Allergy

Author:

Mobarakabadi Maryam¹²,Rajai Nazanin³,Kamyab Kambiz²,Balighi Kamran¹,Mahmoudi Hamidreza¹,Tavakolpour Soheil¹,Nili Ali¹^ORCID,Nikoo Azita²,Mohebi Farnam³,Daneshpazhooh Maryam¹^ORCID

Affiliation:

1. Department of Dermatology Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran

2. Department of Dermatopathology Tehran University of Medical Sciences Tehran Iran

3. Non‐Communicable Diseases Research Center Endocrinology and Metabolism Research Institute Tehran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cia2.12089

Reference13 articles.

1. Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome

2. Pathogenic Relevance of IgG and IgM Antibodies against Desmoglein 3 in Blister Formation in Pemphigus Vulgaris

3. Nail Destruction in Pemphigus vulgaris

4. The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus

5. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and prospects for the diagnosis of pemphigus vulgaris;Expert Review of Clinical Immunology;2021-07-06

2. Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies;BMC Dermatology;2020-10-31